Market Research Logo

Enzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial Analysis

Summary
Canadean's Enzymotec Ltd. : Ingredients - Company Profile, SWOT & Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about Enzymotec Ltd.

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
Enzymotec Ltd., (Enzymotec) develops, manufactures and markets nutritional ingredients and medical foods in Israel. The company offers wide range of lipid based products, such as lipid based medicines, lipid compositions for infant formula and bioactive ingredients for the pharmaceutical and nutritional industries. Enzymotec partners with pharmaceutical companies such as AAK, Elder, DKSH, Teva Pharmaceutical, PFM medical, Daiichi Sankyo, Inc and Sechang Int'l Corp. Its operations are spread in several countries across North America, Europe, Australia, Oceania, the Middle East and Asia. The company also operates research and development, and production facilities in Northern Israel. Enzymotec is headquartered in Migdal Ha'Emeq, Israel.

This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

The SWOT analysis identifies the company’s strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons To Buy
Quickly enhance your understanding of Enzymotec Ltd.

Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

Increase business/sales activities by understanding your competitors’ businesses better.

Recognize potential partnerships and suppliers.

Key Highlights
Enzymotec Ltd., (Enzymotec) develops, manufactures and markets nutritional ingredients and medical foods in Israel. The company offers wide range of lipid based products, such as lipid based medicines, lipid compositions for infant formula and bioactive ingredients for the pharmaceutical and nutritional industries. Enzymotec partners with pharmaceutical companies such as AAK, Elder, DKSH, Teva Pharmaceutical, PFM medical, Daiichi Sankyo, Inc and Sechang Int'l Corp. Its operations are spread in several countries across North America, Europe, Australia, Oceania, the Middle East and Asia. The company also operates research and development, and production facilities in Northern Israel. Enzymotec is headquartered in Migdal Ha'Emeq, Israel.


1 Enzymotec Ltd.
2 Enzymotec Ltd. - Key Employees
3 Enzymotec Ltd. - Key Employees Biographies
4 Enzymotec Ltd. - Major Products and Services
5 Enzymotec Ltd. - History
6 Enzymotec Ltd. - Company Statement
7 Enzymotec Ltd. - Locations and Subsidiaries
7.1 Enzymotec Ltd. - Head Office
7.2 Enzymotec Ltd. - Other Locations and Subsidiaries
8 Enzymotec Ltd. - Business Analysis
8.1 Enzymotec Ltd. - Company Overview
8.2 Enzymotec Ltd. - Business Description
9 Enzymotec Ltd. - SWOT Analysis
9.1 Enzymotec Ltd. - SWOT Analysis - Overview
9.2 Enzymotec Ltd. - Strengths
9.2.1 Strength - Strong Alliance
9.2.2 Strength - Focus on Quality
9.2.3 Strength - Focus on Research and Development
9.3 Enzymotec Ltd. - Weaknesses
9.3.1 Weakness - Decreasing Profitability
9.3.2 Weakness - Narrow Product Portfolio
9.4 Enzymotec Ltd. - Opportunities
9.4.1 Opportunity - Upsurge of Lifestyle Diseases
9.4.2 Opportunity - Positive Outlook for the Global Pharmaceutical Industry
9.4.3 Opportunity - Growing Global Functional Food Market
9.5 Enzymotec Ltd. - Threats
9.5.1 Threat - Stringent Regulations
9.5.2 Threat - Environmental Concerns
9.5.3 Threat - Foreign Exchange Risks
10 Enzymotec Ltd. - Company Financial Analysis
10.1 Enzymotec Ltd. - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
11 Enzymotec Ltd. - Interim ratios
11.1.1 Enzymotec Ltd. - Financial ratios: Capital Market Ratios
11.2 Enzymotec Ltd. - Financial Performance and Ratio Charts
11.2.1 Enzymotec Ltd. - Revenue and Operating margin
11.2.2 Enzymotec Ltd. - Asset and Liabilities
11.2.3 Enzymotec Ltd. - Operational Efficiency
11.2.4 Enzymotec Ltd. - Solvency
11.2.5 Enzymotec Ltd. - Valuation
11.3 Enzymotec Ltd. - Competitive Benchmarking
11.3.1 Enzymotec Ltd. - Market Capitalization
11.3.2 Enzymotec Ltd. - Efficiency
11.3.3 Enzymotec Ltd. - Valuation
11.3.4 Enzymotec Ltd. - Turnover: Inventory and Asset
12 Enzymotec Ltd. - Mergers & Acquisitions and Partnerships
12.1 Enzymotec Ltd. - M&A and Partnerships Strategy
13 Enzymotec Ltd. - Recent Developments
14 Appendix
14.1 Methodology
14.2 Enzymotec Ltd. - Ratio Definitions
14.3 Disclaimer
List of Tables
Table 1: Enzymotec Ltd. - Key Employees
Table 2: Enzymotec Ltd. - Key Employees Biographies
Table 3: Enzymotec Ltd. - Major Products and Services
Table 4: Enzymotec Ltd. - History
Table 5: Enzymotec Ltd. - Subsidiaries
Table 6: Enzymotec Ltd. - Annual ratios
Table 7: Enzymotec Ltd. - Interim ratios
Table 8: Enzymotec Ltd. - Capital Market Ratios
List of Figures
Figure 1: Enzymotec Ltd. - Revenue and Operating Profit
Figure 2: Enzymotec Ltd. - Asset and Liabilities
Figure 3: Enzymotec Ltd. - Operational Efficiency
Figure 4: Enzymotec Ltd. - Solvency
Figure 5: Enzymotec Ltd. - Valuation
Figure 6: Enzymotec Ltd. - Market Capitalization
Figure 7: Enzymotec Ltd. - Efficiency
Figure 8: Enzymotec Ltd. - Valuation
Figure 9: Enzymotec Ltd. - Turnover: Inventory and Asset

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report